Beijing Chunlizhengda Medical Instruments Co., Ltd.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: CNE100001TP1

HKD

8.94

-0.65 (-6.78%)

Jul 17

HKG

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

PW Medtech Group Ltd.

Modern Dental Group Ltd.

Shanghai INT Medical Instruments Co., Ltd.

Essex Bio-Technology Ltd.

Beijing Chunlizhengda Medical Instruments Co., Ltd.

Zylox-Tonbridge Medical Technology Co., Ltd.

Sisram Medical Ltd.

Acotec Scientific Holdings Ltd.

Shanghai Conant Optical Co., Ltd.

MicroPort CardioFlow Medtech Corp.

Venus Medtech (Hangzhou), Inc.

Why is Beijing Chunlizhengda Medical Instruments Co., Ltd. ?

High Debt company with Weak Long Term Fundamental Strength

The company is Net-Debt Free

Flat results in Jun 22

NO KEY NEGATIVE TRIGGERS

With ROE of 8.51%, it has a Very Expensive valuation with a 0.23 Price to Book Value

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -42.69%, its profits have risen by 131.8% ; the PEG ratio of the company is 0

Below par performance in long term as well as near term

Along with generating -42.69% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Beijing Chunlizhengda Medical Instruments Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Beijing Chunlizhengda Medical Instruments Co., Ltd.

-42.69%

-0.09

52.79%

Hang Seng Hong Kong

0.26%

0.01

20.12%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-4.19%

EBIT Growth (5y)

11.02%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.62

Sales to Capital Employed (avg)

0.37

Tax Ratio

9.49%

Dividend Payout Ratio

52.00%

Pledged Shares

Institutional Holding

ROCE (avg)

23.05%

ROE (avg)

8.74%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.23

EV to EBIT

-5.25

EV to EBITDA

-4.70

EV to Capital Employed

-1.48

EV to Sales

-1.39

PEG Ratio

0.02

Dividend Yield

4.26%

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

8.51%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Beijing Chunlizhengda Medical Instruments Co., Ltd.

Raw Material Cost

Fallen by -6.41% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales